Company Information

  

Address: C/O ADMA BIOLOGICS, INC.
465 STATE ROUTE 17 
City: RAMSEY 
State: NJ 
Zip Code: 07446 
Telephone: (201) 478-5552 

Description of Business

Primary SIC Code: 2836
(As filed with the SEC)  

Unless the context otherwise requires, references in this Business section to "ADMA," "ADMA Biologics," the "Company," "we," "us" and "our" refer to ADMA Biologics, Inc., a Delaware corporation, as well as its wholly- owned and indirectly owned subsidiaries, ADMA Plasma Biologics, Inc., a Delaware corporation, ADMA Bio Centers Georgia Inc., a Delaware corporation ("ADMA BioCenters") and ADMA BioManufacturing, LLC, a Delaware limited liability company ("ADMA BioManufacturing"). Overview We are a vertically integrated commercial biopharmaceutical and specialty immunoglobulin company that manufactures, markets and develops specialty plasma-derived biologics for the treatment of immune deficiencies and prevention of certain infectious diseases. Our targeted patient populations include immune-compromised individuals who suffer from an underlying immune deficiency disorder or who may be immune-suppressed for medical reasons.  ... More ...  

Per Share Overview

Date 12-mos Rolling EPS Dividend P/E Ratio
03/2018-1.79NAN/E
12/2017-1.91NAN/E
09/2017-2.02NAN/E
06/2017-1.74NAN/E
03/2017-1.69NAN/E
12/2016-1.61NAN/E
03/2016-1.79NAN/E
12/2015-1.73NAN/E

Key Financial Ratios and Statistics

FYE: 12/31

Profitability 2017 Leverage 2017
Net Inc/Comm Equity-0.23Total Liab/Total Assets0.63
Net Inc/Total Assets-0.41Total Liab/Inv Cap0.69
Net Inc/Inv Cap-0.44Total Liab/Comm Equity0.35
Pretax Inc/Net Sales-1.92Interest Coverage Ratio-12.32
Net Inc/Net Sales-1.92Curr Debt/EquityNA
Cash Flow/Net Sales-1.64LTD/Equity0.63
SG&A/NetSales1.08Total Debt/Equity0.63
Asset Utilization   Liquidity  
Net Receivables Turnover9.29Quick Ratio5.35
Inventory Turnover3.31Current Ratio6.69
Inventory Day Sales0.01Net Rec/Curr Assets0.06
Net Sales/Work Cap0.42Inv/Curr Assets0.20
Net Sales/PP&E0.75  

Income Statement (Millions)

  3/31/2018 12/31/2017 9/30/2017 6/30/2017
Total Revenues(Net Sales) 4.04 12.00 4.73 3.40
Cost of Goods Sold 12.24 11.92 11.29 4.33
Selling & Admin Exps 6.84 7.03 5.78 6.04
Operating Income -16.53 -10.54 -14.43 -8.40
Interest Exp 1.32 1.24 0.78 0.64
Pretax Income -17.82 -12.98 -15.20 -9.04
Other Income 0.03 -1.20 0.01 0.01
Net Income Bef Extraordinary ... NA NA NA NA
Net Income -17.82 -12.98 -15.20 -9.04

Balance Sheet (Millions)

Assets 3/31/2018 12/31/2017 9/30/2017 6/30/2017
Cash & Short Term Investments 27.62 44.61 13.60 25.57
Receivables - Total 3.66 3.88 1.50 2.29
Inventories - Total 12.44 12.63 13.42 13.15
Total Current Assets 46.42 63.17 31.44 44.27
Net Property, Plant & Equipment 30.62 30.47 29.76 28.63
Total Assets 91.14 108.02 72.81 84.64
Liabilities        
Accounts Payable 9.30 9.24 13.02 8.82
Debt in Current Liabilities NA 0.00 0.00 6.67
Total Current Liabilities 9.44 9.44 13.34 15.65
Long-Term Debt 25.62 25.37 14.53 21.98
Total Liabilities 68.11 67.69 59.82 56.96
Stockholder's Equity        
Minority Interest NA NA NA NA
Preferred Stock 0.00 0.00 0.00 0.00
Common Stock 0.00 0.00 0.00 0.00
Retained Earnings -168.52 -150.69 -137.71 -122.51
Treasury Stock NA NA NA NA
Total Stockholders' Equity 23.03 40.33 12.99 27.68
Total Liabilities and Stockholders' Equity 91.14 108.02 72.81 84.64

Cash Flow Summary (Millions)

Categories 3/31/2018 12/31/2017 9/30/2017 6/30/2017
Net Cash Provided by Operating Activities -16.43 -13.36 -9.74 -8.78
Net Cash Provided by Investing Activities -0.55 -2.01 -0.57 12.65
Net Cash Provided by Financing Activities -0.00 50.37 -1.66 13.15

Annual Summary Data (Millions)

Year Sales Net Income EPS
12/20133.07-15.53-2.38
12/20145.92-16.81-1.81
12/20157.18-17.97-1.73
12/201610.66-19.52-1.61
12/201722.76-43.76-1.91
Growth Rates65.04----

Stock Ownership

Type Date(Q,M) No. Owners Shares Held (000s) % Own
Institutional06/30/183816,97236.62




Report Date : 7/16/2018

Powered By Edgar Online © 2018EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.